Senna ๐
๐ฟ Senna is a stimulant laxative derived from the leaves and pods of the Cassia senna plant.
It promotes colonic motility and stool evacuation, typically acting within 6โ12 hours.
Best taken at night for a morning bowel movement.
๐ง About
- Contains sennosides A and B, which are anthraquinone glycosides.
- Activated by colonic bacteria into rhein anthrone, the compound responsible for its stimulant effects.
- Commonly combined with a softening agent (e.g. docusate) for postoperative or opioid-related constipation.
- Widely used in hospitals for bowel regulation โ especially in the elderly, immobile, or opioid-treated patients.
- Typical onset of action: 6โ12 hours.
โ๏ธ Mode of Action
- Stimulates colonic peristalsis by directly irritating the mucosal nerve plexus (Auerbachโs and Meissnerโs plexuses).
- Increases water and electrolyte secretion into the intestinal lumen.
- Reduces colonic water reabsorption, producing softer, looser stools.
- Unlike bulk-forming laxatives, senna acts primarily on smooth muscle rather than stool volume.
๐ฏ Indications
- Short-term treatment of constipation.
- Opioid-induced constipation (with docusate or macrogol).
- Pre-procedural bowel evacuation (e.g. before colonoscopy or surgery).
- Occasionally used for postoperative bowel stimulation following abdominal surgery (after excluding obstruction).
๐ Dose
- Tablets: Senna 15โ30 mg (usually 2โ4 tablets) taken at night for effect the next morning.
- Oral liquid: 10โ20 mL once daily at night, titrated to effect.
- Adjust dose to produce one soft bowel movement daily; reduce once regularity is established.
โ ๏ธ Cautions
- Ensure adequate hydration and mobility โ dehydration increases cramping risk.
- Chronic use (>1 week) may lead to hypokalaemia or atonic colon (โlazy bowelโ).
- Prolonged or excessive use may cause melanosis coli (harmless pigmentation of colonic mucosa).
- Use cautiously in frail or malnourished patients prone to electrolyte disturbances.
๐ซ Contraindications
- Intestinal obstruction or ileus.
- Undiagnosed abdominal pain (rule out obstruction or appendicitis first).
- Severe inflammatory bowel disease or acute surgical abdomen.
๐ Adverse Effects
- Common: abdominal cramps, urgency, diarrhoea.
- Occasional: electrolyte loss (especially potassium), weakness, nausea.
- Rare: hepatotoxicity or pseudomelanosis coli with long-term use (benign and reversible).
๐คฐ Pregnancy & Lactation
- Considered safe for short-term use in pregnancy โ little systemic absorption.
- Preferred stimulant if osmotic agents (e.g. lactulose) ineffective.
- Compatible with breastfeeding; minimal transfer into breast milk.
๐ฉบ Practical Prescribing Notes
- Combine with stool-softeners (e.g. docusate sodium) for opioid-related constipation.
- If ineffective, switch to or add an osmotic laxative (e.g. macrogol).
- For frail older adults: use the lowest effective dose and review every few days.
- Reinforce dietary fibre, hydration, and mobilisation.
๐ก Teaching Tip
- Senna demonstrates the neuro-secretory mechanism of bowel stimulation โ unlike osmotics that act via water retention.
- Good for contrasting with bulk-formers (e.g. ispaghula) and osmotics (e.g. lactulose).
- Explain to learners: โSenna irritates; lactulose lubricates; ispaghula bulks.โ
๐ References
- BNF: Senna
- NICE CKS: Constipation in adults (2024)
- Camilleri M. NEJM 2021;385:488โ498 โ Mechanisms and management of chronic constipation.